W Döll

476 total citations
27 papers, 377 citations indexed

About

W Döll is a scholar working on Pharmaceutical Science, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W Döll has authored 27 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W Döll's work include Drug Solubulity and Delivery Systems (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastrointestinal motility and disorders (2 papers). W Döll is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastrointestinal motility and disorders (2 papers). W Döll collaborates with scholars based in United States, Germany and United Kingdom. W Döll's co-authors include Erik P. Sandefer, Richard C. Page, George A. Digenis, U. Yun Ryo, Giancarlo Santus, Leesun Kim, T. Gold, Sean N. Tucker, James Ermer and Peter Timmins and has published in prestigious journals such as Gastroenterology, Scientific Reports and International Journal of Pharmaceutics.

In The Last Decade

W Döll

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Döll United States 11 167 75 39 39 36 27 377
Erik P. Sandefer United States 14 292 1.7× 80 1.1× 55 1.4× 41 1.1× 57 1.6× 27 577
Priyanka Arora United States 8 457 2.7× 29 0.4× 119 3.1× 12 0.3× 28 0.8× 15 696
Maria del Carmen Dios-Viéitez Spain 16 135 0.8× 63 0.8× 162 4.2× 25 0.6× 29 0.8× 24 643
Jeremy A. Bartlett United States 10 46 0.3× 28 0.4× 60 1.5× 17 0.4× 42 1.2× 17 388
Sirkka Nykänen Finland 11 77 0.5× 76 1.0× 45 1.2× 13 0.3× 45 1.3× 15 394
Anand Srivastava India 10 159 1.0× 19 0.3× 71 1.8× 7 0.2× 34 0.9× 23 392
M.J. Dennis United States 11 37 0.2× 139 1.9× 32 0.8× 11 0.3× 33 0.9× 14 386
Ronald van der Geest Netherlands 14 313 1.9× 130 1.7× 108 2.8× 16 0.4× 25 0.7× 19 651
Mohamad H. Rahimy United States 14 26 0.2× 44 0.6× 76 1.9× 10 0.3× 19 0.5× 30 499
Muhammad Naeem Aamir Pakistan 16 223 1.3× 46 0.6× 74 1.9× 19 0.5× 9 0.3× 51 582

Countries citing papers authored by W Döll

Since Specialization
Citations

This map shows the geographic impact of W Döll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Döll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Döll more than expected).

Fields of papers citing papers by W Döll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Döll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Döll. The network helps show where W Döll may publish in the future.

Co-authorship network of co-authors of W Döll

This figure shows the co-authorship network connecting the top 25 collaborators of W Döll. A scholar is included among the top collaborators of W Döll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Döll. W Döll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Döll, W, Erik P. Sandefer, Richard C. Page, et al.. (2024). Su1778 RESULTS OF HUMAN DEVICE FUNCTION STUDIES FOR THE NAVICAP™ TARGETED ORAL DELIVERY PLATFORM IN HEALTHY VOLUNTEERS AND PATIENTS WITH UC. Gastroenterology. 166(5). S–809. 1 indexed citations
3.
Mair, Stuart, W Döll, Erik P. Sandefer, et al.. (2020). The effects of ulimorelin, a ghrelin agonist, on liquid gastric emptying and colonic transit in humans. Neurogastroenterology & Motility. 32(3). e13784–e13784. 9 indexed citations
4.
5.
Brown, Jonathan, Caly Chien, Peter Timmins, et al.. (2013). Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug. Journal of Pharmaceutical Sciences. 102(6). 1742–1751. 44 indexed citations
6.
Ermer, James, W Döll, Patrick Martin, et al.. (2011). Pharmacokinetics of Lisdexamfetamine Dimesylate after Targeted Gastrointestinal Release or Oral Administration in Healthy Adults. Drug Metabolism and Disposition. 40(2). 290–297. 18 indexed citations
7.
Ermer, James, W Döll, Erik P. Sandefer, et al.. (2011). Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate. Clinical Drug Investigation. 31(6). 357–370. 31 indexed citations
8.
Al-Ghananeem, Abeer M., et al.. (2008). Gamma scintigraphy for testing bioequivalence: A case study on two cromolyn sodium nasal spray preparations. International Journal of Pharmaceutics. 357(1-2). 70–76. 20 indexed citations
9.
Gao, Jing, Munir Hussain, David A. Gray, et al.. (2007). Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz). Journal of Pharmaceutical Sciences. 96(11). 2970–2977. 25 indexed citations
10.
Damle, Bharat, et al.. (2002). Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers. British Journal of Clinical Pharmacology. 54(3). 255–261. 11 indexed citations
12.
Digenis, George A., Erik P. Sandefer, Richard C. Page, & W Döll. (1998). Gamma scintigraphy: an evolving technology in pharmaceutical formulation development-Part 1. 1(3). 100–108. 24 indexed citations
13.
Digenis, George A., Erik P. Sandefer, Richard C. Page, & W Döll. (1998). Gamma scintigraphy: an evolving technology in pharmaceutical formulation development—Part 2. 1(4). 160–165. 9 indexed citations
14.
Santus, Giancarlo, Erik P. Sandefer, Richard C. Page, et al.. (1997). An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. European Journal of Pharmaceutics and Biopharmaceutics. 44(1). 39–52. 67 indexed citations
15.
Döll, W, et al.. (1995). Biodegradable Indium-111 Labeled Microspheres for in Vivo Evaluation of Distribution and Elimination. Pharmaceutical Research. 12(12). 2060–2064. 15 indexed citations
16.
Hahn, Helmut, J Bockemühl, & W Döll. (1976). [Use of Nessler's reagent for recognition of lysine, ornithine, and arginine decomposition by gramnegative fermentative bacteria (author's transl)].. PubMed. 236(1). 120–6. 1 indexed citations
17.
Friedrich, Benjamin, et al.. (1971). 318. Früherkennung der akuten posttraumatischen Osteomyelitis durch bakteriologische Untersuchung der Redon-Drainagen. Langenbeck s Archives of Surgery. 329(1). 1163–1163. 6 indexed citations
18.
Döll, W. (1961). Bedeutung und Anwendung grenzflächenaktiver Verbindungen in der Bakteriologie. Fette Seifen Anstrichmittel. 63(11). 1071–1084.
19.
Döll, W. (1958). [Interference of interfacial compounds with bacteriological & serological test procedures].. PubMed. 172(3-4). 296–7. 1 indexed citations
20.
Döll, W. (1955). [Simple colorimetric determination of chloromycetin in aqueous solution].. PubMed. 5(2). 97–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026